Home › NDC Lookup › RxCUI directory › RxCUI 198859

Sodium bicarbonate 325 MG Oral Tablet — RxCUI 198859

RxNorm drug concept · Semantic clinical drug
RxCUI 198859 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198859
Official nameSodium bicarbonate 325 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asNaHCO3 325 MG Oral Tablet; sodium bicarbonate 324 MG Oral Tablet; sodium bicarbonate 5 Grains Oral Tablet
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)7,798 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sodium Bicarbonate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. By mouth, it relieves heartburn, sour stomach and acid indigestion. On the skin, some products ease itching from insect bites and poison ivy. The injecti...
  • Labels for products like Rapidol and De La Cruz Sodium Bicarbonate Antacid say to dissolve it completely in water and drink it. It can be repeated every couple of hours up to a dai...
  • Don't use the maximum dose for more than 2 weeks unless a doctor tells you to. If your symptoms last longer than 2 weeks, stop and see your doctor.
  • Antacids can interact with some prescription drugs. Please check with me or your doctor before using it if you take any.
📖 Read our full Sodium Bicarbonate guide →

🕸️ Concept Web — How Sodium bicarbonate 325 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sodium bicarbonate 325 MG Oral Tablet RxCUI 198859

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sodium bicarbonate 36676
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sodium bicarbonate Oral Tablet 373899
    • Sodium bicarbonate Oral Product 1159311
    • Sodium bicarbonate Pill 1159313
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sodium bicarbonate 325 MG 316682

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium bicarbonate 325 MG SCDC · 316682
  • Sodium bicarbonate Oral Tablet SCDF · 373899
  • Sodium bicarbonate Oral Product SCDG · 1159311
  • Sodium bicarbonate Pill SCDG · 1159313

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 198859 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00536-1046-10 1000 TABLET in 1 BOTTLE (0536-1046-10) Sodium Bicarbonate Antacid Rugby Laboratories 2015-03-25
54738-0035-03 1000 TABLET in 1 BOTTLE (54738-035-03) Sodium Bicarbonate Antacid Richmond Pharmaceuticals, Inc. 2015-06-01
55681-0072-02 200 TABLET in 1 BOTTLE (55681-072-02) Sodium Bicarbonate 5 gr TWIN MED LLC 2026-03-01
55681-0307-02 200 TABLET in 1 BOTTLE (55681-307-02) Sodium Bicarbonate 5 gr TWIN MED LLC 2022-06-30
70369-0002-01 1000 TABLET in 1 BOTTLE (70369-002-01) Sodium Bicarbonate 5 gr (325 mg) CitraGen Pharmaceuticals Inc. 2018-04-20
Observed labelers: TWIN MED LLC (2) · CitraGen Pharmaceuticals Inc. (1) · Richmond Pharmaceuticals, Inc. (1) · Rugby Laboratories (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0148
Range $0.0148–$0.0148 · middle 50% $0.0148–$0.0148 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.